These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 26371011)

  • 21. Preventing biofilms of clinically relevant organisms using bacteriophage.
    Donlan RM
    Trends Microbiol; 2009 Feb; 17(2):66-72. PubMed ID: 19162482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of Bacteriophages in Removing Biofilms of
    Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
    Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
    [No Abstract]   [Full Text] [Related]  

  • 23. Active bacteriophage biocontrol and therapy on sub-millimeter scales towards removal of unwanted bacteria from foods and microbiomes.
    Abedon ST
    AIMS Microbiol; 2017; 3(3):649-688. PubMed ID: 31294181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against
    Kumaran D; Taha M; Yi Q; Ramirez-Arcos S; Diallo JS; Carli A; Abdelbary H
    Front Microbiol; 2018; 9():127. PubMed ID: 29459853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the Complex Phage-Host Interactions in Biofilm Communities.
    Pires DP; Melo LDR; Azeredo J
    Annu Rev Virol; 2021 Sep; 8(1):73-94. PubMed ID: 34186004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophage-based biocontrol technology to enhance the efficiency of wastewater treatment and reduce targeted bacterial biofilms.
    Shivaram KB; Bhatt P; Applegate B; Simsek H
    Sci Total Environ; 2023 Mar; 862():160723. PubMed ID: 36496019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage Therapy: A New Horizon in the Antibacterial Treatment of Oral Pathogens.
    Shlezinger M; Khalifa L; Houri-Haddad Y; Coppenhagen-Glazer S; Resch G; Que YA; Beyth S; Dorfman E; Hazan R; Beyth N
    Curr Top Med Chem; 2017; 17(10):1199-1211. PubMed ID: 27770768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria.
    Almeida GMF; Laanto E; Ashrafi R; Sundberg LR
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial Efficacy of Two Commercially Available Bacteriophage Formulations, Staphylococcal Bacteriophage and PYO Bacteriophage, Against Methicillin-Resistant
    Tkhilaishvili T; Wang L; Tavanti A; Trampuz A; Di Luca M
    Front Microbiol; 2020; 11():110. PubMed ID: 32117136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophage Adsorption: Likelihood of Virion Encounter with Bacteria and Other Factors Affecting Rates.
    Abedon ST
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of bacteriophages to biocontrol oral biofilms.
    Szafrański SP; Winkel A; Stiesch M
    J Biotechnol; 2017 May; 250():29-44. PubMed ID: 28108235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotechnological applications of bacteriophages: State of the art.
    Harada LK; Silva EC; Campos WF; Del Fiol FS; Vila M; Dąbrowska K; Krylov VN; Balcão VM
    Microbiol Res; 2018; 212-213():38-58. PubMed ID: 29853167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human oral phageome.
    Szafrański SP; Slots J; Stiesch M
    Periodontol 2000; 2021 Jun; 86(1):79-96. PubMed ID: 33690937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophage treatment of carbapenemase-producing
    Santiago AJ; Burgos-Garay ML; Kartforosh L; Mazher M; Donlan RM
    AIMS Microbiol; 2020; 6(1):43-63. PubMed ID: 32226914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix-trapped viruses can prevent invasion of bacterial biofilms by colonizing cells.
    Bond MC; Vidakovic L; Singh PK; Drescher K; Nadell CD
    Elife; 2021 Jul; 10():. PubMed ID: 34240700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Biofilm Effect of Bacteriophages and Antibiotics against Uropathogenic
    Mukane L; Racenis K; Rezevska D; Petersons A; Kroica J
    Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551363
    [No Abstract]   [Full Text] [Related]  

  • 38. An overview of the current state of phage therapy for the treatment of biofilm-related infections.
    Pires DP; Meneses L; Brandão AC; Azeredo J
    Curr Opin Virol; 2022 Apr; 53():101209. PubMed ID: 35240424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
    Alves DR; Perez-Esteban P; Kot W; Bean JE; Arnot T; Hansen LH; Enright MC; Jenkins AT
    Microb Biotechnol; 2016 Jan; 9(1):61-74. PubMed ID: 26347362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophages and Lysins in Biofilm Control.
    Łusiak-Szelachowska M; Weber-Dąbrowska B; Górski A
    Virol Sin; 2020 Apr; 35(2):125-133. PubMed ID: 32125643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.